Franklin Alternative Strategies Funds has released its latest financial report through an NPORT-P filing, showcasing its financial health and investment strategies. This filing is crucial as it provides transparency to investors and stakeholders about the fund's performance and asset management.
The report indicates that Franklin Alternative Strategies Funds, a Delaware-based investment entity, has total assets amounting to approximately $834 million and net assets of around $568 million. The fund's liabilities are reported at about $266 million, reflecting its current financial obligations.
Background
Franklin Alternative Strategies Funds operates under the Central Index Key (CIK) 0001535538. The fund is classified as an investment entity and is registered under the SEC file number 811-22641. Its business address is located at One Franklin Parkway, San Mateo, California.
What the Filing Says
The NPORT-P filing, dated October 29, 2026, provides a snapshot of the fund's financial status as of August 31, 2026. It details that the fund's total assets are $834,451,094.09, with total liabilities of $266,295,333.08, resulting in net assets of $568,155,761.01. The fund has invested approximately $75 million across various asset classes, and it has not reported any significant amounts owed to banks or affiliated companies.
Impact
This financial disclosure is significant for investors and stakeholders as it highlights the fund's investment strategy and financial health. The reported figures may influence investor confidence and decisions regarding the fund's future performance. Additionally, the filing provides insights into the competitive landscape of the investment management industry, where transparency and performance metrics are critical for attracting and retaining investors.
What's Next
The filing does not say what happens next. However, investors and analysts will likely monitor the fund's performance closely, especially in light of the competitive pressures within the investment management sector.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






